PLEOMORPHIC RHABDOMYOSARCOMA
Clinical trials for PLEOMORPHIC RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new PLEOMORPHIC RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for PLEOMORPHIC RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized radiation aims to spare sarcoma patients from Long-Term side effects
Disease control Recruiting nowThis study is testing whether selecting certain patients to receive proton radiation instead of standard X-ray radiation before sarcoma surgery can reduce long-term side effects while maintaining the same treatment effectiveness. For each of the 110 adult participants in Norway, …
Matched conditions: PLEOMORPHIC RHABDOMYOSARCOMA
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Proton beam trial aims to zap inoperable tumors with higher, safer doses
Disease control Recruiting nowThis study is testing whether a newer type of radiation therapy, called proton beam therapy, can be given at a higher dose to better control inoperable soft tissue sarcomas. The goal is to see if this approach stops tumor growth for at least two years without increasing side effe…
Matched conditions: PLEOMORPHIC RHABDOMYOSARCOMA
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC